# TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis

> **NCT00228228** · PHASE3 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 80 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** T cell vaccination

## Key facts

- **NCT ID:** NCT00228228
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00228228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00228228, "TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00228228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*